Terminated NA INTERVENTIONAL 2-arm NCT02844023

Biomarkers in Giant Cells Arteritis (BioACG)

Sponsor: University Hospital, Grenoble

Interventions Clinical evaluation Dosage of biomarkers Imaging Ophthalmologic examination Paraclinical evaluation

Updated 6 times since 2017 Last updated: Apr 16, 2019 Started: Jan 31, 2015 Primary completion: Jan 14, 2019 Completion: Jan 14, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

recruitment failure

Other terminated trials from University Hospital, Grenoble

See all terminations from University Hospital, Grenoble

Listed as NCT02844023, this NA trial focuses on Giant Cells Arteritis and remains terminated or withdrawn. Sponsored by University Hospital, Grenoble, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
May 2019 — Jan 2021 [monthly]

Terminated NA

Status: Recruiting → Terminated
Jun 2018 — May 2019 [monthly]

Recruiting NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Grenoble

Data source: University Hospital, Grenoble

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• La Tronche, France